Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-06-27

FDA Approved: NAFTIN — Original Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved NAFTIN (naftifine hydrochloride) under an Original Application from Legacy Pharma USA Inc. for topical treatment of dermatophytic skin infections. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAFTIN (NAFTIFINE HYDROCHLORIDE)

Snippet

ORIG AP for NAFTIN (NAFTIFINE HYDROCHLORIDE)